Kyong-Sik Yun
Founder & CEO, Ybrain
Yun Kyongsik received a BS (2006) and a PhD (2010) in brain engineering at the Korea Advanced Institute of Science and Technology (KAIST). Yun then moved to the California Institute of Technology (Caltech), where he published two innovative Nature papers on artificial telepathy and noninvasive neural network modulation.
In February 2013 he founded Ybrain, where he developed a hardware-software platform that enables simultaneous monitoring and modulation of brain function. He applied this technology to conduct safe and effective clinical trials for the treatment of Alzheimer's disease. These trials are the world’s first "remote” treatment of the disease by use of a wearable medical device.
Yun’s pioneering technology has far-reaching implications for the future of human brain health. It is set to play an integral role in the treatment of brain disorders such as Parkinson’s disease, autism and psychiatric illnesses. He believes this safe, effective and mobile technology will revolutionize brain science and the medical industry.
Yun continues to investigate new methods of understanding and improving brain function.